查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1365722

荐椎神经刺激市场：按产品、按用途、按最终用户：2023-2032 年全球机会分析和产业预测

Sacral Nerve Stimulation Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 226 Pages | 商品交期: 2-3个工作天内

价格

由于设备需求的增加，荐椎神经刺激市场预计从 2023 年到 2032 年将出现 5.2% 的显着增长率 - 根据联合市场研究公司发布的新研究报告《荐椎神经刺激市场》，荐椎神经刺激2022 年市值为4.2266 亿美元，预计2023 年至2032 年年复合成长率为 5.2%，到 2032 年将达到 7.021 亿美元。

荐神经刺激市场-IMG1

该报告可以定制。

  • 法规指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 扩大公司简介列表
  • 历史市场资料
  • 主要参与企业的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）
  • SWOT分析

目录

第1章简介

第2章执行摘要

第3章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响要素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
      • 泌尿器官系统患病增加
      • 荐骨神经刺激器的技术进步
      • 医疗报销制度的可用性
    • 抑制因素
      • 荐椎神经刺激高成本且副作用大
    • 机会
      • 新兴市场的成长机会
  • COVID-19 市场影响分析

第4章荐椎神经刺激市场：按产品

  • 概述
  • 装置
  • 配件

第5章荐椎神经刺激市场：依用途

  • 概述
  • 尿失禁和大便失禁
  • 慢性肛裂
  • 其他的

第6章荐椎神经刺激市场：依最终用户分类

  • 概述
  • 医院
  • 专科诊所
  • 其他的

第7章荐椎神经刺激市场：按地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 澳洲
    • 印度
    • 韩国
    • 其他的
  • 拉丁美洲/中东/非洲
    • 巴西
    • 沙乌地阿拉伯
    • 南非
    • 其他的

第8章竞争形势

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争仪表板
  • 竞争热图
  • 2022年主要企业定位

第9章公司简介

  • Medtronic plc
  • Beijing PINS Medical Co., Ltd.
  • Axonics, Inc.
  • Saluda Medical Pty Ltd.
Product Code: A03518

The sacral nerve stimulation market is likely to experience a significant growth rate of 5.2% from 2023-2032 owing to increase in demand devices segment - Allied Market Research. According to a new report published by Allied Market Research, titled, "Sacral Nerve Stimulation Market," The sacral nerve stimulation market was valued at $422.66 million in 2022, and is estimated to reach $702.1 million by 2032, growing at a CAGR of 5.2% from 2023 to 2032.

Sacral Nerve Stimulation Market - IMG1

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • SWOT Analysis

Key Market Segments

By Product

  • Devices
  • Accessories

By Application

  • Urinary and Fecal Incontinence
  • Chronic Anal Fissure
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Axonics, Inc.
    • Beijing PINS Medical Co., Ltd.
    • Saluda Medical Pty Ltd.
    • Medtronic plc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in prevalence of urological incontinence
      • 3.4.1.2. Technological advancements in sacral nerve stimulation devices
      • 3.4.1.3. Availability of medical reimbursement schemes
    • 3.4.2. Restraints
      • 3.4.2.1. High cost and side effects of Sacral nerve stimulation
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth opportunities in emerging markets
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: SACRAL NERVE STIMULATION MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Devices
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Accessories
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: SACRAL NERVE STIMULATION MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Urinary and Fecal Incontinence
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Chronic Anal Fissure
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: SACRAL NERVE STIMULATION MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Specialty Clinics
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: SACRAL NERVE STIMULATION MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Product
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Product
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Product
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Product
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Product
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Product
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Product
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Product
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Product
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Product
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Product
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Product
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Product
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Product
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. Australia
      • 7.4.5.3.1. Market size and forecast, by Product
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. India
      • 7.4.5.4.1. Market size and forecast, by Product
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Product
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Product
      • 7.4.5.6.2. Market size and forecast, by Application
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Product
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Product
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Product
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Product
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Product
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Medtronic plc
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.0. Key strategic moves and developments
  • 9.2. Beijing PINS Medical Co., Ltd.
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
  • 9.3. Axonics, Inc.
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.0. Key strategic moves and developments
  • 9.4. Saluda Medical Pty Ltd.
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 02. SACRAL NERVE STIMULATION MARKET FOR DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. SACRAL NERVE STIMULATION MARKET FOR ACCESSORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 05. SACRAL NERVE STIMULATION MARKET FOR URINARY AND FECAL INCONTINENCE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. SACRAL NERVE STIMULATION MARKET FOR CHRONIC ANAL FISSURE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. SACRAL NERVE STIMULATION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. GLOBAL SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 09. SACRAL NERVE STIMULATION MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. SACRAL NERVE STIMULATION MARKET FOR SPECIALTY CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. SACRAL NERVE STIMULATION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. SACRAL NERVE STIMULATION MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA SACRAL NERVE STIMULATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 17. U.S. SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 18. U.S. SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. U.S. SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. CANADA SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 21. CANADA SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. CANADA SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. MEXICO SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. EUROPE SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE SACRAL NERVE STIMULATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 30. GERMANY SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. GERMANY SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. GERMANY SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. FRANCE SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. FRANCE SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. UK SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 37. UK SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. UK SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. ITALY SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 40. ITALY SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. ITALY SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. SPAIN SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 43. SPAIN SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. REST OF EUROPE SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 46. REST OF EUROPE SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 47. REST OF EUROPE SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. ASIA-PACIFIC SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 49. ASIA-PACIFIC SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. ASIA-PACIFIC SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC SACRAL NERVE STIMULATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 52. JAPAN SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 53. JAPAN SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. JAPAN SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. CHINA SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. CHINA SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. CHINA SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. AUSTRALIA SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 59. AUSTRALIA SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. AUSTRALIA SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. INDIA SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 62. INDIA SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 63. INDIA SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH KOREA SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH KOREA SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH KOREA SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. REST OF ASIA-PACIFIC SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 70. LAMEA SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 71. LAMEA SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 72. LAMEA SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. LAMEA SACRAL NERVE STIMULATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 74. BRAZIL SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 75. BRAZIL SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. BRAZIL SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. SAUDI ARABIA SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 78. SAUDI ARABIA SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. SAUDI ARABIA SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. SOUTH AFRICA SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 81. SOUTH AFRICA SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 82. SOUTH AFRICA SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. REST OF LAMEA SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 84. REST OF LAMEA SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 85. REST OF LAMEA SACRAL NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 87. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 88. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 89. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 90. MEDTRONIC PLC: KEY STRATERGIES
  • TABLE 91. BEIJING PINS MEDICAL CO., LTD.: KEY EXECUTIVES
  • TABLE 92. BEIJING PINS MEDICAL CO., LTD.: COMPANY SNAPSHOT
  • TABLE 93. BEIJING PINS MEDICAL CO., LTD.: PRODUCT SEGMENTS
  • TABLE 94. BEIJING PINS MEDICAL CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 95. AXONICS, INC.: KEY EXECUTIVES
  • TABLE 96. AXONICS, INC.: COMPANY SNAPSHOT
  • TABLE 97. AXONICS, INC.: PRODUCT SEGMENTS
  • TABLE 98. AXONICS, INC.: PRODUCT PORTFOLIO
  • TABLE 99. AXONICS, INC.: KEY STRATERGIES
  • TABLE 100. SALUDA MEDICAL PTY LTD.: KEY EXECUTIVES
  • TABLE 101. SALUDA MEDICAL PTY LTD.: COMPANY SNAPSHOT
  • TABLE 102. SALUDA MEDICAL PTY LTD.: PRODUCT SEGMENTS
  • TABLE 103. SALUDA MEDICAL PTY LTD.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. SACRAL NERVE STIMULATION MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF SACRAL NERVE STIMULATION MARKET,2022-2032
  • FIGURE 03. TOP INVESTMENT POCKETS IN SACRAL NERVE STIMULATION MARKET (2023-2032)
  • FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. LOW THREAT OF NEW ENTRANTS
  • FIGURE 06. LOW THREAT OF SUBSTITUTES
  • FIGURE 07. MODERATE INTENSITY OF RIVALRY
  • FIGURE 08. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 09. GLOBAL SACRAL NERVE STIMULATION MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 10. SACRAL NERVE STIMULATION MARKET, BY PRODUCT, 2022(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF SACRAL NERVE STIMULATION MARKET FOR DEVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF SACRAL NERVE STIMULATION MARKET FOR ACCESSORIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. SACRAL NERVE STIMULATION MARKET, BY APPLICATION, 2022(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF SACRAL NERVE STIMULATION MARKET FOR URINARY AND FECAL INCONTINENCE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF SACRAL NERVE STIMULATION MARKET FOR CHRONIC ANAL FISSURE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF SACRAL NERVE STIMULATION MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. SACRAL NERVE STIMULATION MARKET, BY END USER, 2022(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF SACRAL NERVE STIMULATION MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF SACRAL NERVE STIMULATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF SACRAL NERVE STIMULATION MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. SACRAL NERVE STIMULATION MARKET BY REGION, 2022(%)
  • FIGURE 22. U.S. SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 23. CANADA SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 24. MEXICO SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. GERMANY SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. FRANCE SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. UK SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. ITALY SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. SPAIN SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. REST OF EUROPE SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. JAPAN SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. CHINA SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. AUSTRALIA SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. INDIA SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. SOUTH KOREA SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. REST OF ASIA-PACIFIC SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. BRAZIL SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SAUDI ARABIA SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. SOUTH AFRICA SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. REST OF LAMEA SACRAL NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
  • FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
  • FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
  • FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 45. COMPETITIVE DASHBOARD
  • FIGURE 46. COMPETITIVE HEATMAP: SACRAL NERVE STIMULATION MARKET
  • FIGURE 47. TOP PLAYER POSITIONING, 2022
  • FIGURE 48. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 50. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 51. AXONICS, INC.: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 52. AXONICS, INC.: REVENUE SHARE BY REGION, 2021 (%)